The mTORC1–C/EBPβ–OSM axis thus defines a critical immune–metabolic pathway sustaining myocardial inflammation and represents a tractable therapeutic target for preventing the progression of autoimmune myocarditis to chronic inflammatory cardiomyopathy. Here, CEBPB is linked to autoimmune myocarditis.